dihydrolipoic acid has been researched along with Chronic Illness in 1 studies
dihydrolipoic acid: RN given refers to parent cpd without isomeric designation
dihydrolipoic acid : A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects.
dihydrolipoate : The conjugate base of dihydrolipoic acid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Smith, AR | 1 |
Shenvi, SV | 1 |
Widlansky, M | 1 |
Suh, JH | 1 |
Hagen, TM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) Randomised, Double-blind,Placebo-controlled Multicentre Trial With 4 Parallel Groups[NCT00328601] | Phase 3 | 170 participants | Interventional | 2005-02-28 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for dihydrolipoic acid and Chronic Illness
Article | Year |
---|---|
Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress.
Topics: Animals; Antioxidants; Chelation Therapy; Chronic Disease; Coenzymes; Diabetic Neuropathies; Free Ra | 2004 |